Publication: A de novo L330S point mutation in thyroid hormone receptor beta gene in a Thai female with resistance to thyroid hormone
Issued Date
1999-01-01
Resource Type
ISSN
09188959
Other identifier(s)
2-s2.0-0033375175
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Endocrine Journal. Vol.46, No.6 (1999), 825-829
Suggested Citation
Sasitorn Ditudompo, Boonsong Ongphiphadhanakul, Suwannee Chanprasertyotin, Rajata Rajatanavin A de novo L330S point mutation in thyroid hormone receptor beta gene in a Thai female with resistance to thyroid hormone. Endocrine Journal. Vol.46, No.6 (1999), 825-829. doi:10.1507/endocrj.46.825 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/25363
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
A de novo L330S point mutation in thyroid hormone receptor beta gene in a Thai female with resistance to thyroid hormone
Other Contributor(s)
Abstract
In the present study, we report a Thai female with a de novo mutation in thyroid hormone receptor-β (TRβ) gene causing resistance to thyroid hormone (RTH). The patient was a 19 year-old woman who presented with goiter for 1 year. Except for tachycardia she had no signs of thyrotoxicosis. Previously she was treated with propylthiouracil based on the diagnosis of thyrotoxicosis for 9 months and her goiter became more enlarged. The patient was the only child of the family. Her parents were alive and healthy, and did not have goiter or any other thyroid diseases. Physical examination revealed no sign of thyrotoxicosis. Her thyroid gland was diffusely enlarged with an estimated weight of 100 gm. Laboratory determinations revealed elevated free T4, T3 and nonsuppressed TSH levels. Exon 9 of the TRβ gene was amplified by PCR and the DNA sequence was determined by dye terminator cycle sequencing. Heterozygous point mutation in which T was replaced by C was detected at position 1274 (TTG to TCG) corresponding to a leucine to serine substitution at codon 330. No mutation was found in the parents indicating that the mutation was de novo. The nucleotide change created a restriction site for Taq 1 restriction endonuclease and the mutation was confirmed by restriction fragments length polymorphism. The same nucleotide change has been reported in a family with RTH.